Cardiopulmonary Impact of Particulate Air Pollution in High-Risk Populations,Journal of the American College of Cardiology

当前位置： X-MOL 学术 › J. Am. Coll. Cardiol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Cardiopulmonary Impact of Particulate Air Pollution in High-Risk Populations
Journal of the American College of Cardiology ( IF 21.7 ) Pub Date : 2020-12-01 , DOI: 10.1016/j.jacc.2020.10.020
Jonathan D Newman ₁ , Deepak L Bhatt ₂ , Sanjay Rajagopalan ₃ , John R Balmes ₄ , Michael Brauer ₅ , Patrick N Breysse ₆ , Alison G M Brown ₇ , Mercedes R Carnethon ₈ , Wayne E Cascio ₉ , Gwen W Collman ₁₀ , Lawrence J Fine ₇ , Nadia N Hansel ₁₁ , Adrian Hernandez ₁₂ , Judith S Hochman ₁₃ , Michael Jerrett ₁₄ , Bonnie R Joubert ₁₅ , Joel D Kaufman ₁₆ , Ali O Malik ₁₇ , George A Mensah ₁₈ , David E Newby ₁₉ , Jennifer L Peel ₂₀ , Jeffrey Siegel ₂₁ , David Siscovick ₂₂ , Betsy L Thompson ₂₃ , Junfeng Zhang ₂₄ , Robert D Brook ₂₅

Affiliation

Division of Cardiology and the Center for the Prevention of Cardiovascular Disease, New York University Grossman School of Medicine, New York, New York, USA.
Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston, Massachusetts, USA.
Harrington Heart and Vascular Institute, University Hospitals, Case Western Reserve University, Cleveland, Ohio, USA.
Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, University of California, San Francisco, California, USA.
School of Population and Public Health, The University of British Columbia, Vancouver, British Columbia, Canada.
National Center for Environmental Health/Agency for Toxic Substances and Disease Registry, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Washington, DC, USA.
Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Center for Public Health and Environmental Assessment, U.S. Environmental Protection Agency, Durham, North Carolina, USA.
National Institute of Environmental Health Sciences, Durham, North Carolina, USA.
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Clinical Research, Duke University School of Medicine, Durham, North Carolina, USA.
New York University Grossman School of Medicine, New York, New York, USA.
Fielding School of Public Health, University of California, Los Angeles, California, USA.
Population Health Branch, Division of Extramural Research and Training, National Institute of Environmental Health Sciences, Durham, North Carolina, USA.
Departments of Environmental & Occupational Health Sciences, Medicine, and Epidemiology, University of Washington, Seattle, Washington, USA.
Saint Luke's Mid America Heart Institute, Kansas City, Missouri, USA.
Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute, Washington, DC, USA.
British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom.
Department of Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, Colorado, USA.
Department of Civil and Mineral Engineering, and the Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Division of Research, Evaluation, and Policy, The New York Academy of Medicine, New York, New York, USA.
Division for Heart Disease and Stroke Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Nicholas School of the Environment & Duke Global Health Institute, Duke University, Durham, North Carolina, USA.
Division of Cardiovascular Diseases, Wayne State University, Detroit, Michigan, USA.

Fine particulate air pollution <2.5 μm in diameter (PM2.5) is a major environmental threat to global public health. Multiple national and international medical and governmental organizations have recognized PM2.5 as a risk factor for cardiopulmonary diseases. A growing body of evidence indicates that several personal-level approaches that reduce exposures to PM2.5 can lead to improvements in health endpoints. Novel and forward-thinking strategies including randomized clinical trials are important to validate key aspects (e.g., feasibility, efficacy, health benefits, risks, burden, costs) of the various protective interventions, in particular among real-world susceptible and vulnerable populations. This paper summarizes the discussions and conclusions from an expert workshop, Reducing the Cardiopulmonary Impact of Particulate Matter Air Pollution in High Risk Populations, held on May 29 to 30, 2019, and convened by the National Institutes of Health, the U.S. Environmental Protection Agency, and the U.S. Centers for Disease Control and Prevention.

中文翻译：

空气颗粒物污染对高危人群心肺的影响

直径<2.5微米的细颗粒空气污染（PM2.5）是对全球公共卫生的主要环境威胁。多个国家和国际医学和政府组织已将 PM2.5 视为心肺疾病的危险因素。越来越多的证据表明，几种减少 PM2.5 暴露的个人方法可以改善健康终点。包括随机临床试验在内的新颖且具有前瞻性的策略对于验证各种保护性干预措施的关键方面（例如可行性、功效、健康益处、风险、负担、成本）非常重要，特别是在现实世界的易感人群和弱势人群中。本文总结了 2019 年 5 月 29 日至 30 日由美国国立卫生研究院、美国环境保护署、和美国疾病控制与预防中心。

更新日期：2020-12-01

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南11